-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-15%
Martin Dow
Daplyza 5mg Tab 14 S
Rated 4.5 out of 5 (48)SKU HP-05349
A tablet containing Dapagliflozin, indicated for Diabetes.
Rs. 455Rs. 535-15%
You save Rs. 80
60 Capsules
In StockSet your city for an exact delivery date
In stock at selected branches
Quantity
Daplyza 5mg Tab 14 S quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 455
What it is used for: Diabetes.
Indications as listed by the manufacturer: It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
How it works: Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.
Active ingredient: Dapagliflozin.
Reported side effects: Infections and infestations : Common: Vulvovaginitis, balanitis and related genital infections, Urinary tract infection (including pyelonephritis and urosepsis) Uncommon: Fungal infection Metabolism and nutrition disorders . Very common: Hypoglycaemia (when used with sulphonylurea or insulin) Uncommon: Volume depletion, Thirst Rare: Diabetic ketoacidosisNervous system disorders : Common: DizzinessGastrointestinal disorders : Uncommon: Constipation, Dry mouth Skin and subcutaneous tissue disorders Common: Rash Musculoskeletal and connective tissue disorders : Common: Back pain Not Known: Fracture of BoneRenal and urinary disorders Common: Dysuria, Polyuria Uncommon: Nocturia, Renal impairmentReproductive system and breast disorders Uncommon: Vulvovaginal pruritus, Pruritus genital
Known drug interactions: ACE inhibitors , Flouroquinolones , Somatostatin Analogues , SGLT2 inhibitors
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : The recommended starting dose of dapagliflozin is 5 mg once daily, taken in the morning, with or without food. In patients tolerating dapagliflozin 5 mg once daily who require additional glycemic control, the dose can be increased to 10 mg once daily. In patients with volume depletion, correcting this condition prior to initiation of dapagliflozin is recommended. Children : Not Recommended. Always consult your doctor or pharmacist for dose adjustments.
Active ingredient: Dapagliflozin. Labelled strength: 5mg.
- Contraindications : History of a serious hypersensitivity reaction to dapagliflozin. Severe renal impairment, end-stage renal disease (ESRD), or patients on dialysis.
- Insulin and insulin secretagogues are known to cause hypoglycemia. It can increase the risk of hypoglycemia when combined with insulin or an insulin secretagogue. Therefore, a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when these agents are used in combination with Dapagliflozin.
- It should not be used in patients with active bladder cancer. In patients with prior history of bladder cancer, the benefits of glycemic control versus unknown risks for cancer recurrence with dapagliflozin should be considered.
- It increases the risk of genital mycotic infections. Patients with a history of genital mycotic infections were more likely to develop genital mycotic infections.
- It causes intravascular volume contraction. Symptomatic hypotension can occur after initiating dapagliflozin particularly in patients with impaired renal function (eGFR less than 60 mL/min/1.73 m2), elderly patients, or patients on loop diuretics. Before initiating dapagliflozin in patients, volume status should be assessed and corrected. Monitor for signs and symptoms of hypotension after initiating therapy.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Daplyza Laboratories (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 548 verified ratings
- 5★75%
- 4★0%
- 3★25%
- 2★0%
- 1★0%
- Adnan YousufVerified Purchase4 Aug 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
- Usman TariqVerified Purchase28 Jul 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Bilal AhmedVerified Purchase21 Jul 2026Rated 5.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Karachi the next day.
- Zainab H.Verified Purchase29 Jun 2026Rated 5.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Diabetes.
Indications as listed by the manufacturer: It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
How it works: Sodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.
Active ingredient: Dapagliflozin.
Reported side effects: Infections and infestations : Common: Vulvovaginitis, balanitis and related genital infections, Urinary tract infection (including pyelonephritis and urosepsis) Uncommon: Fungal infection Metabolism and nutrition disorders . Very common: Hypoglycaemia (when used with sulphonylurea or insulin) Uncommon: Volume depletion, Thirst Rare: Diabetic ketoacidosisNervous system disorders : Common: DizzinessGastrointestinal disorders : Uncommon: Constipation, Dry mouth Skin and subcutaneous tissue disorders Common: Rash Musculoskeletal and connective tissue disorders : Common: Back pain Not Known: Fracture of BoneRenal and urinary disorders Common: Dysuria, Polyuria Uncommon: Nocturia, Renal impairmentReproductive system and breast disorders Uncommon: Vulvovaginal pruritus, Pruritus genital
Known drug interactions: ACE inhibitors , Flouroquinolones , Somatostatin Analogues , SGLT2 inhibitors
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Adults : The recommended starting dose of dapagliflozin is 5 mg once daily, taken in the morning, with or without food. In patients tolerating dapagliflozin 5 mg once daily who require additional glycemic control, the dose can be increased to 10 mg once daily. In patients with volume depletion, correcting this condition prior to initiation of dapagliflozin is recommended. Children : Not Recommended. Always consult your doctor or pharmacist for dose adjustments.
Active ingredient: Dapagliflozin. Labelled strength: 5mg.
- Contraindications : History of a serious hypersensitivity reaction to dapagliflozin. Severe renal impairment, end-stage renal disease (ESRD), or patients on dialysis.
- Insulin and insulin secretagogues are known to cause hypoglycemia. It can increase the risk of hypoglycemia when combined with insulin or an insulin secretagogue. Therefore, a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when these agents are used in combination with Dapagliflozin.
- It should not be used in patients with active bladder cancer. In patients with prior history of bladder cancer, the benefits of glycemic control versus unknown risks for cancer recurrence with dapagliflozin should be considered.
- It increases the risk of genital mycotic infections. Patients with a history of genital mycotic infections were more likely to develop genital mycotic infections.
- It causes intravascular volume contraction. Symptomatic hypotension can occur after initiating dapagliflozin particularly in patients with impaired renal function (eGFR less than 60 mL/min/1.73 m2), elderly patients, or patients on loop diuretics. Before initiating dapagliflozin in patients, volume status should be assessed and corrected. Monitor for signs and symptoms of hypotension after initiating therapy.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Daplyza Laboratories (Pvt) Ltd.. Country of origin: Pakistan.
4.5
Rated 4.5 out of 548 verified ratings
- 5★75%
- 4★0%
- 3★25%
- 2★0%
- 1★0%
- Adnan YousufVerified Purchase4 Aug 2026Rated 5.0 out of 5
Works as expected. Took about three weeks to notice a difference, which the product page had already told me to expect.
- Usman TariqVerified Purchase28 Jul 2026Rated 3.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Bilal AhmedVerified Purchase21 Jul 2026Rated 5.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Karachi the next day.
- Zainab H.Verified Purchase29 Jun 2026Rated 5.0 out of 5
Arrived in a plain bag, nothing written on the outside. Good for something you would rather not advertise.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
Martin DowDaplyza 5mg Tab 14 SRs. 455Rated 4.5 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 3,440Rs. 3,765
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
